FDA reopens comment period for Transparency Task Force

08/31/2009 | HealthImaging.com

The FDA has reopened the comment period for the Transparency Task Force through Nov. 6 in preparation for a scheduled second public meeting this fall. The agency is seeking comments on how it can make activity and decision-making data available to the public.

View Full Article in:

HealthImaging.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Director of Operations - GBS
Mayo Clinic
Rochester, MN
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Senior Vice President, Clinical Affairs & Strategic Partnerships
America's Health Insurance Plans (AHIP)
Washington, DC